Home > Insider Trading > Filing (0001415889-23-008197)

Filing Details

Accession Number:: 0001415889-23-008197
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-05-17 16:17:15
Reporting Period:: 2023-05-15

Accepted Time:: 2023-05-17 16:17:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1109354	Bruker Corp	BRKR	Laboratory Analytical Instruments (3826)	043110160

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1133649	H Frank Laukien	C/O Bruker Corporation 40 Manning Road Billerica MA 01821	President & Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2023-05-15	137,718	$72.60	38,352,034	No	4	S	Direct
Common Stock	Disposition	2023-05-15	47,657	$73.18	38,262,287	No	4	S	Direct
Common Stock	Disposition	2023-05-16	12,917	$73.03	38,210,993	No	4	S	Direct
Common Stock	Disposition	2023-05-16	1,708	$73.68	38,180,634	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,046,499	Indirect	By Former Spouse
Common Stock	337,087	Indirect	By Son
Common Stock	336,607	Indirect	By Daughter
Common Stock	201,702	Indirect	As UTMA Custodian for Son
Common Stock	71,728	Indirect	As UTMA Custodian for Son
Common Stock	492	Indirect	By Former Spouse

Footnotes

The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.00 to $73.00, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.01 to 73.71, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.59 to $73.58, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.59 to $73.78, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The Reporting Person disclaims beneficial ownership of 1,046,499 shares held by the Reporting Person's former spouse- Robyn Laukien, 492 shares held by the Reporting Person's former spouse- Ruta Laukien, 337,087 shares held by the Reporting Person's adult son and 336,607 shares held by the Reporting Person's adult daughter, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.